drugset / Trial / NCT02293967
Mass Balance Study of MT-1303
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the absorption, metabolism and excretion of MT-1303 in healthy subjects.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amiselimod | Small molecule | 0.4 mg | Oral |